Miromatrix to Report First Quarter 2023 Financial Results
EDEN PRAIRIE, Minn., April 27, 2023 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (NASDAQ:MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today announced that the Company will report financial results for the first quarter 2023 after market close on Thursday, May 11, 2023. Company management will host a corresponding conference call beginning at 3:30 pm Central Time / 4:30 pm Eastern Time.
Related news for (MIRO)
- United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger
- CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation
- CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation